Biolife Solutions
(BLFS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,481 | 31,902 | 66,945 | 95,386 | 24,161 |
| Marketable Securities | 49,473 | 49,864 | 21,635 | 9,198 | 10,211 |
| Receivables | 10,842 | 10,060 | 9,167 | 9,168 | 17,918 |
| Inventories | 27,825 | 27,690 | 27,566 | 29,013 | 32,179 |
| TOTAL | $126,566 | $125,432 | $131,129 | $148,761 | $89,383 |
| Non-Current Assets | |||||
| PPE Net | 11,101 | 7,665 | 6,605 | 6,084 | 17,709 |
| Investments And Advances | 19,444 | 18,471 | 20,050 | 5,623 | 5,879 |
| Intangibles | 219,754 | 220,453 | 221,161 | 221,863 | 243,156 |
| Other Non-Current Assets | 15,216 | 15,219 | 16,196 | 17,156 | 25,525 |
| TOTAL | $265,515 | $261,808 | $264,012 | $250,726 | $292,269 |
| Total Assets | $392,081 | $387,240 | $395,141 | $399,487 | $381,652 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,492 | 10,051 | 10,449 | 10,943 | 12,231 |
| Accounts payable and accrued liabilities | 2,890 | 3,209 | 3,297 | 3,573 | 3,838 |
| Accrued Expenses | 10,905 | 9,311 | 8,213 | 12,451 | 8,449 |
| Other current liabilities | 3,681 | 3,575 | 3,929 | 4,256 | 4,537 |
| TOTAL | $27,146 | $28,312 | $27,723 | $32,734 | $32,166 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | N/A | 2,499 | 4,997 | 7,823 |
| Other Non-Current Liabilities | 11,007 | 11,598 | 12,165 | 12,723 | 15,189 |
| TOTAL | $11,196 | $11,773 | $14,794 | $17,844 | $24,025 |
| Total Liabilities | $38,342 | $40,085 | $42,517 | $50,578 | $56,191 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,148 | 47,905 | 47,561 | 47,000 | 46,387 |
| Common Shares | 48 | 48 | 48 | 47 | 46 |
| Retained earnings | -350,766 | -351,387 | -335,549 | -335,101 | -347,560 |
| Other shareholders' equity | 130 | 71 | 33 | 24 | -208 |
| TOTAL | $353,739 | $347,155 | $352,624 | $348,909 | $325,461 |
| Total Liabilities And Equity | $392,081 | $387,240 | $395,141 | $399,487 | $381,652 |